The current set of more than 100 marketed macrocycle drugs are almost exclusively derived from natural products, and yet this structural class has been poorly explored within drug discovery.
Researchers at the University of Oklahoma have developed a breakthrough method of adding a single nitrogen atom to molecules, ...
Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...
The deal expands a deal to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using ...
The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other industries.
Advanced Micro Devices Inc. is going head-to-head with bigger rival Nvidia Corp. in artificial intelligence-backed drug discovery with news of a new partnership and investment in startup Absci ...
Announcing a new publication for Acta Materia Medica journal. Complex biological mechanisms and unidentified therapeutic targets for amyotrophic lateral sclerosis (ALS) significantly hinder the develo ...
Using its unique structure-based drug discovery system, Cocrystal Pharma is developing antiviral therapies for influenza, coronaviruses, and other viruses. With up to 650,000 fatalities yearly and ...
The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public.
This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at all stages of the drug discovery and design journey. Robust process ...
Footage filmed by Syrian journalist Obada Jbara shows an abandoned drug factory, which he said belonged to the Assad regime, filled with bags of what Jbara described as “Captagon, drugs, and crystal ...